Gilly Regev
Role: Associate
Site: CDL-Vancouver
Stream: Biomedical Engineering
Dr. Gilly Regev is a skilled entrepreneur and innovator specializing in infectious disease research. She earned her Ph.D. in analytical and bioanalytical chemistry from the Hebrew University of Jerusalem.
Dr. Regev served as the CSO of Bovicor, an animal health company, before co-founding SaNOtize in 2017. As the CEO of SaNOtize, she spearheaded the development of new formulations, oversaw clinical trials, created intellectual property, and liaised with regulatory authorities. Under her leadership, the company secured over $45 million in funding and manufactured, received regulatory approvals and commercialized products globally.
In recognition of her contributions, Dr. Regev was honored with the YWCA Women of Distinction Award for Entrepreneur and Innovator of the Year in 2021. In 2022, she was named one of the Top 25 Women Leaders in Biotechnology by the Healthcare Technology Report.